» Articles » PMID: 33262512

Host Antibacterial Defense of 6-10 Gy γ-irradiated Mice Subjected to Lentiviral Vector-based Gas5 Gene Therapy

Overview
Journal Gene Ther
Date 2020 Dec 2
PMID 33262512
Authors
Affiliations
Soon will be listed here.
Abstract

Gut bacteria-associated sepsis is a serious concern in patients with gastrointestinal acute radiation syndrome (GIARS). In our previous studies, all mice exposed to 8 Gy of whole body γ-irradiation (8 Gy GIARS-mice) died by sepsis stemming from bacterial translocation. M1Mϕ located in the bacterial translocation site (i.e., the mesenteric lymph nodes, MLNs) have been characterized as major antibacterial effector cells. However, M2bMϕ, inhibitor cells for M1Mϕ polarization, predominated in the MLNs of these mice. The reduced expression of long noncoding RNA Gas5 was associated with M2bMϕ polarization. In this study, we tried to reduce the mortality rate of 8 Gy GIARS-mice through Gas5 gene transduction using lentivirus (Gas5 lentivirus). After Gas5 lentivirus injection, Gas5 RNA was overexpressed in MLN-F4/80 cells of 8 Gy GIARS-mice, and these cells were identified as non-M2bMϕ. All of the 8 Gy GIARS-mice injected with Gas5 lentivirus survived 30 days or more after irradiation, and bacterial translocation and subsequent sepsis were shown to be minimal in these mice. These results indicate that the antibacterial resistance of 8 Gy GIASR-mice can be restored through the modulation of M2bMϕ located in the bacterial translocation site by Gas5 transduction.

References
1.
Waselenko J, MacVittie T, Blakely W, Pesik N, Wiley A, Dickerson W . Medical management of the acute radiation syndrome: recommendations of the Strategic National Stockpile Radiation Working Group. Ann Intern Med. 2004; 140(12):1037-51. DOI: 10.7326/0003-4819-140-12-200406150-00015. View

2.
Igaki H, Nakagawa K, Uozaki H, Akahane M, Hosoi Y, Fukayama M . Pathological changes in the gastrointestinal tract of a heavily radiation-exposed worker at the Tokai-mura criticality accident. J Radiat Res. 2007; 49(1):55-62. DOI: 10.1269/jrr.07058. View

3.
Dainiak N . Medical management of acute radiation syndrome and associated infections in a high-casualty incident. J Radiat Res. 2018; 59(suppl_2):ii54-ii64. PMC: 5941165. DOI: 10.1093/jrr/rry004. View

4.
Singh V, Seed T . A review of radiation countermeasures focusing on injury-specific medicinals and regulatory approval status: part I. Radiation sub-syndromes, animal models and FDA-approved countermeasures. Int J Radiat Biol. 2017; 93(9):851-869. DOI: 10.1080/09553002.2017.1332438. View

5.
Suzuki F, Loucas B, Ito I, Asai A, Suzuki S, Kobayashi M . Survival of Mice with Gastrointestinal Acute Radiation Syndrome through Control of Bacterial Translocation. J Immunol. 2018; 201(1):77-86. PMC: 6008223. DOI: 10.4049/jimmunol.1701515. View